Deferred Tax Assets, Valuation Allowance of Co-Diagnostics, Inc. from 31 Dec 2016 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary: Co-Diagnostics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2016 to 31 Dec 2024.
Co-Diagnostics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $14,884,382, a 115% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Co-Diagnostics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$14,884,382	+$7,945,553	+115%	31 Dec 2024	10-K	27 Mar 2025	2024	FY
Q4 2023	$6,938,829			31 Dec 2023	10-K	27 Mar 2025	2024	FY
Q4 2019	$5,161,500	+$1,309,000	+34%	31 Dec 2019	10-K	25 Mar 2021	2020	FY
Q4 2018	$3,852,500	+$1,311,100	+52%	31 Dec 2018	10-K	30 Mar 2020	2019	FY
Q4 2017	$2,541,400	+$944,900	+59%	31 Dec 2017	10-K	01 Apr 2019	2018	FY
Q4 2016	$1,596,500			31 Dec 2016	10-K	28 Mar 2018	2017	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.